Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
276 hedge funds and large institutions have $520M invested in Avanos Medical in 2025 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 92 increasing their positions, 72 reducing their positions, and 48 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 72
0.25% more ownership
Funds ownership: 96.72% → 96.97% (+0.25%)
5% less capital invested
Capital invested by funds: $547M → $520M (-$27.4M)
3% less funds holding
Funds holding: 286 → 276 (-10)
15% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 48
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$8.4M |
| 2 |
Millennium Management
New York
|
+$7.95M |
| 3 |
AC
Armistice Capital
New York
|
+$5.43M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.41M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$4.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Paradice Investment Management
Denver,
Colorado
|
-$15.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.2M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$10.3M |
| 4 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
-$9.92M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$5.54M |
AVNS Hedge Fund Activity: Q3 2025 in Review
276 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2025, worth a combined $520M — down 5% from $547M a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of AVNS and 41 opened new positions — a net loss of 7 holders — while 72 trimmed existing stakes and 92 added.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $8.4M. The largest seller was Paradice Investment Management, exiting entirely with an estimated $15.4M sold.
- 276 institutional investors held Avanos Medical (AVNS) as of Q3 2025, down from 286 in Q2 2025.
- Funds reported $520M of Avanos Medical stock for Q3 2025, down 5% quarter-over-quarter.
- 41 funds opened new Avanos Medical positions in Q3 2025 and 48 closed out, a net change of -7 holders.
- The largest Avanos Medical buyer in Q3 2025 was T. Rowe Price Investment Management, an estimated $8.4M added.
- The largest Avanos Medical seller in Q3 2025 was Paradice Investment Management, an estimated $15.4M sold.
Based on aggregated 13F filings for Q3 2025.